HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells

Lihua Wu, Haiyang Yu, Yuhan Zhao, Cen Zhang, Jiabei Wang, Xuetian Yue, Qifeng Yang, Wenwei Hu

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Leukemia inhibitory factor (LIF), a multi-functional cytokine, has a complex role in cancer. While LIF induces the differentiation of several myeloid leukemia cells and inhibits their growth, it also promotes tumor progression, metastasis and chemoresistance in many solid tumors. LIF is frequently overexpressed in a variety of human tumors and its overexpression is often associated with poor prognosis of patients. Currently, the mechanism for LIF overexpression in tumor cells is not wellunderstood. Here, we report that hypoxia, a hallmark of solid tumors, induced LIF mRNA expression in human colorectal cancer cells. Analysis of LIF promoter revealed several hypoxia-responsive elements (HREs) that can specifically interact with and be transactivated by HIF-2α but not HIF-1α. Consistently, ectopic expression of HIF-2α but not HIF-1α transcriptionally induced LIF expression levels in cells. Knockdown of endogenous HIF-2α but not HIF-1α by siRNA largely abolished the induction of LIF by hypoxia in cells. Furthermore, there is a strong association of HIF-2α overexpression with LIF overexpression in human colorectal cancer specimens. In summary, results from this study demonstrate that hypoxia induces LIF expression in human cancer cells mainly through HIF-2α, which could be an important underlying mechanism for LIF overexpression in human cancers.

Original languageEnglish (US)
Pages (from-to)4406-4417
Number of pages12
JournalOncotarget
Volume6
Issue number6
DOIs
StatePublished - Jan 1 2015

Fingerprint

Leukemia Inhibitory Factor
Colorectal Neoplasms
Neoplasms
Hypoxia
Cell Hypoxia
Myeloid Leukemia
Myeloid Cells
Small Interfering RNA

All Science Journal Classification (ASJC) codes

  • Oncology

Keywords

  • HIF-2α
  • Hypoxia
  • Hypoxia-responsive element
  • Leukemia inhibitory factor

Cite this

Wu, Lihua ; Yu, Haiyang ; Zhao, Yuhan ; Zhang, Cen ; Wang, Jiabei ; Yue, Xuetian ; Yang, Qifeng ; Hu, Wenwei. / HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells. In: Oncotarget. 2015 ; Vol. 6, No. 6. pp. 4406-4417.
@article{c2587bf340714aff9c658c97e4f8f8ba,
title = "HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells",
abstract = "Leukemia inhibitory factor (LIF), a multi-functional cytokine, has a complex role in cancer. While LIF induces the differentiation of several myeloid leukemia cells and inhibits their growth, it also promotes tumor progression, metastasis and chemoresistance in many solid tumors. LIF is frequently overexpressed in a variety of human tumors and its overexpression is often associated with poor prognosis of patients. Currently, the mechanism for LIF overexpression in tumor cells is not wellunderstood. Here, we report that hypoxia, a hallmark of solid tumors, induced LIF mRNA expression in human colorectal cancer cells. Analysis of LIF promoter revealed several hypoxia-responsive elements (HREs) that can specifically interact with and be transactivated by HIF-2α but not HIF-1α. Consistently, ectopic expression of HIF-2α but not HIF-1α transcriptionally induced LIF expression levels in cells. Knockdown of endogenous HIF-2α but not HIF-1α by siRNA largely abolished the induction of LIF by hypoxia in cells. Furthermore, there is a strong association of HIF-2α overexpression with LIF overexpression in human colorectal cancer specimens. In summary, results from this study demonstrate that hypoxia induces LIF expression in human cancer cells mainly through HIF-2α, which could be an important underlying mechanism for LIF overexpression in human cancers.",
keywords = "HIF-2α, Hypoxia, Hypoxia-responsive element, Leukemia inhibitory factor",
author = "Lihua Wu and Haiyang Yu and Yuhan Zhao and Cen Zhang and Jiabei Wang and Xuetian Yue and Qifeng Yang and Wenwei Hu",
year = "2015",
month = "1",
day = "1",
doi = "10.18632/oncotarget.3017",
language = "English (US)",
volume = "6",
pages = "4406--4417",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "6",

}

Wu, L, Yu, H, Zhao, Y, Zhang, C, Wang, J, Yue, X, Yang, Q & Hu, W 2015, 'HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells', Oncotarget, vol. 6, no. 6, pp. 4406-4417. https://doi.org/10.18632/oncotarget.3017

HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells. / Wu, Lihua; Yu, Haiyang; Zhao, Yuhan; Zhang, Cen; Wang, Jiabei; Yue, Xuetian; Yang, Qifeng; Hu, Wenwei.

In: Oncotarget, Vol. 6, No. 6, 01.01.2015, p. 4406-4417.

Research output: Contribution to journalArticle

TY - JOUR

T1 - HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells

AU - Wu, Lihua

AU - Yu, Haiyang

AU - Zhao, Yuhan

AU - Zhang, Cen

AU - Wang, Jiabei

AU - Yue, Xuetian

AU - Yang, Qifeng

AU - Hu, Wenwei

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Leukemia inhibitory factor (LIF), a multi-functional cytokine, has a complex role in cancer. While LIF induces the differentiation of several myeloid leukemia cells and inhibits their growth, it also promotes tumor progression, metastasis and chemoresistance in many solid tumors. LIF is frequently overexpressed in a variety of human tumors and its overexpression is often associated with poor prognosis of patients. Currently, the mechanism for LIF overexpression in tumor cells is not wellunderstood. Here, we report that hypoxia, a hallmark of solid tumors, induced LIF mRNA expression in human colorectal cancer cells. Analysis of LIF promoter revealed several hypoxia-responsive elements (HREs) that can specifically interact with and be transactivated by HIF-2α but not HIF-1α. Consistently, ectopic expression of HIF-2α but not HIF-1α transcriptionally induced LIF expression levels in cells. Knockdown of endogenous HIF-2α but not HIF-1α by siRNA largely abolished the induction of LIF by hypoxia in cells. Furthermore, there is a strong association of HIF-2α overexpression with LIF overexpression in human colorectal cancer specimens. In summary, results from this study demonstrate that hypoxia induces LIF expression in human cancer cells mainly through HIF-2α, which could be an important underlying mechanism for LIF overexpression in human cancers.

AB - Leukemia inhibitory factor (LIF), a multi-functional cytokine, has a complex role in cancer. While LIF induces the differentiation of several myeloid leukemia cells and inhibits their growth, it also promotes tumor progression, metastasis and chemoresistance in many solid tumors. LIF is frequently overexpressed in a variety of human tumors and its overexpression is often associated with poor prognosis of patients. Currently, the mechanism for LIF overexpression in tumor cells is not wellunderstood. Here, we report that hypoxia, a hallmark of solid tumors, induced LIF mRNA expression in human colorectal cancer cells. Analysis of LIF promoter revealed several hypoxia-responsive elements (HREs) that can specifically interact with and be transactivated by HIF-2α but not HIF-1α. Consistently, ectopic expression of HIF-2α but not HIF-1α transcriptionally induced LIF expression levels in cells. Knockdown of endogenous HIF-2α but not HIF-1α by siRNA largely abolished the induction of LIF by hypoxia in cells. Furthermore, there is a strong association of HIF-2α overexpression with LIF overexpression in human colorectal cancer specimens. In summary, results from this study demonstrate that hypoxia induces LIF expression in human cancer cells mainly through HIF-2α, which could be an important underlying mechanism for LIF overexpression in human cancers.

KW - HIF-2α

KW - Hypoxia

KW - Hypoxia-responsive element

KW - Leukemia inhibitory factor

UR - http://www.scopus.com/inward/record.url?scp=84924234545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924234545&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.3017

DO - 10.18632/oncotarget.3017

M3 - Article

C2 - 25726527

AN - SCOPUS:84924234545

VL - 6

SP - 4406

EP - 4417

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 6

ER -